(Q40672509)

English

Priming of T cells with Ad-transduced DC followed by expansion with peptide-pulsed DC significantly enhances the induction of tumor-specific CD8+ T cells: implications for an efficient vaccination strategy

scientific article published on February 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Priming of T cells with Ad-transduced DC followed by expansion with peptide-pulsed DC significantly enhances the induction of tumor-specific CD8+ T cells: implications for an efficient vaccination strategy (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Helmut Jonuleit

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

author name string

Tuettenberg A

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Tüting T

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Brück J

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Knop J

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Enk AH

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

243-250

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Dendritic cells as adjuvants for immune-mediated resistance to tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Human PBMC-derived dendritic cells transduced with an adenovirus vectorinduce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Persistent, antigen-specific, therapeutic antitumor immunity by dendritic cells genetically modified with an adenoviral vector to express a model tumor antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Dendritic cells loaded with MART-1 peptide or infected with adenoviral construct are functionally equivalent in the induction of tumor-specific cytotoxic T lymphocyte responses in patients with melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

21 January 2018

Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

7 January 2021

based on heuristic

inferred from DOI database lookup

Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of tumor peptide-specific cytotoxic T cells under serum-free conditions by mature human dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8+ T cells in patients with melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenoviral transduction of human 'clinical grade' immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytodiagnosis of malignant melanoma. Immunoperoxidase staining with HMB-45 antibody as an aid to diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301880

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3301880

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40672509&oldid=2203880242"